dc.contributor.author |
Onono, Maricianah
|
|
dc.contributor.author |
Nanda, Kavita
|
|
dc.contributor.author |
Heller, Kate B.
|
|
dc.contributor.author |
Taylor, Doug
|
|
dc.contributor.author |
Yacobson, Irina
|
|
dc.contributor.author |
Heffron, Renee
|
|
dc.contributor.author |
Kasaro, Margaret Phiri
|
|
dc.contributor.author |
Louw, Cheryl
|
|
dc.contributor.author |
Nhlabasti, Zelda
|
|
dc.contributor.author |
Palanee-Phillips, Thesla
|
|
dc.contributor.author |
Smit, Jenni
|
|
dc.contributor.author |
Wakhungu, Imelda
|
|
dc.contributor.author |
Gichangi, Peter B.
|
|
dc.contributor.author |
Mugo, Nelly R.
|
|
dc.contributor.author |
Morrison, Charles
|
|
dc.contributor.author |
Baeten, Jared M.
|
|
dc.date.accessioned |
2021-04-01T05:30:32Z |
|
dc.date.available |
2021-04-01T05:30:32Z |
|
dc.date.issued |
2020 |
|
dc.description.abstract |
OBJECTIVE: The objective was to address bias in contraception efficacy studies through a randomized study trial of
intramuscular depot medroxyprogesterone acetate (DMPA-IM), a copper intrauterine device (IUDs) and a levonorgestrel (LNG) implant.
STUDY DESIGN: We analyzed data from the Evidence for Contraceptive Options and HIV Outcomes Trial, which
assessed HIV incidence among 7829 women from 12 sites in eSwatini, Kenya, South Africa and Zambia seeking
effective contraception and who consented to be randomized to DMPA-IM, copper IUD or LNG implant. We
used Cox proportional hazards regression adjusted for condom use to compare pregnancy incidence during
both perfect and typical (i.e., allowing temporary interruptions) use.
RESULTS: A total of 7710 women contributed to this analysis. Seventy pregnancies occurred during perfect and 85
during typical use. There was no statistically significant difference in perfect use pregnancy incidence among the
methods: 0.61 per 100 woman-years for DMPA-IM [95% confidence interval (CI) 0.36–0.96], 1.06 for copper IUD
(95% CI 0.72–1.50) and 0.63 for LNG implants (95% CI 0.39–0.96). Typical use pregnancy rates were also largely
similar: 0.87 per 100 woman-years for DMPA-IM (95% CI 0.58–1.25), 1.11 for copper IUD (95% CI 0.77–1.54) and
0.63 for LNG implants (95% CI 0.39–0.96).
CONCLUSIONS: In this randomized trial of highly effective contraceptive methods among African women, both perfect and typical use resulted in low pregnancy rates. Our findings provide strong justification for improving access
to a broader range of longer-acting contraceptive options including LNG implants and copper IUD for African
women. |
en_ZA |
dc.description.department |
Family Medicine |
en_ZA |
dc.description.librarian |
pm2021 |
en_ZA |
dc.description.sponsorship |
The Bill & Melinda Gates Foundation, the United States Agency for International Development, the Swedish International Development Cooperation Agency as part of the EDCTP2 program supported by the European Union, the South African Medical Research Council and the United Nations Population Fund. Contraceptive supplies were donated by the Government of South Africa and United States Agency for International Development. |
en_ZA |
dc.description.uri |
https://www.journals.elsevier.com/conx |
en_ZA |
dc.identifier.citation |
Onono, M., Nanda, K., Heller, K.B. et al. 2020, 'Comparison of pregnancy incidence among African women in a randomized trial of intramuscular depot medroxyprogesterone acetate (DMPA-IM), a copper intrauterine device (IUDs) or a levonorgestrel (LNG) implant for contraception', Contraception: X, vol. 2, art. 100026, pp. 1-10. |
en_ZA |
dc.identifier.issn |
2590-1516 |
|
dc.identifier.other |
10.1016/j.conx.2020.100026 |
|
dc.identifier.uri |
http://hdl.handle.net/2263/79145 |
|
dc.language.iso |
en |
en_ZA |
dc.publisher |
Elsevier |
en_ZA |
dc.rights |
© 2020 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
en_ZA |
dc.subject |
Hormonal contraception |
en_ZA |
dc.subject |
Injectables |
en_ZA |
dc.subject |
Implants |
en_ZA |
dc.subject |
Copper intrauterine device |
en_ZA |
dc.subject |
Africa |
en_ZA |
dc.subject |
Pregnancy incidence |
en_ZA |
dc.subject |
Intramuscular depot medroxyprogesterone acetate (DMPA-IM) |
en_ZA |
dc.subject |
Intrauterine device (IUD) |
en_ZA |
dc.subject |
Levonorgestrel (LNG) |
en_ZA |
dc.title |
Comparison of pregnancy incidence among African women in a randomized trial of intramuscular depot medroxyprogesterone acetate (DMPA-IM), a copper intrauterine device (IUDs) or a levonorgestrel (LNG) implant for contraception |
en_ZA |
dc.type |
Article |
en_ZA |